Two days ago the useful lesson in Indian science administration was that the Principal Scientific Adviser's office can convene and cannot fund. This is the other half of the architecture: a fund with ₹1 lakh crore that can fund and does not convene.
On 12 October 2026 the Research, Development and Innovation Fund (RDIF) announced its first cohort of 19 Second Level Fund Managers (SLFMs). The Empowered Group of Secretaries (EGoS), meeting on 8 October 2026, approved 14 Alternative Investment Funds (AIFs) and 5 Focused Research Organisations (FROs), with a total RDIF commitment of ₹7,131 crore. The ₹1 lakh crore RDI Scheme itself was launched by the Prime Minister in November 2025.
The phrase to notice in all of that is "Second Level". It tells you the entire design.
A fund of funds, and why that is a deliberate choice
The government is not investing in companies. It is investing in fund managers, who will invest in companies.
That is what a fund-of-funds is, and the naming is literal: the RDIF is the first-level fund, and the nineteen institutions approved are the second level. They will channel RDIF capital to Eligible Technology Enterprises (ETEs) undertaking research, development and innovation.
The reasoning behind the structure is sound and worth stating, because it is a genuine piece of institutional humility. The state is comparatively good at one thing and comparatively bad at another. It is good at identifying strategic priorities — which technologies India must not import, which capabilities are security-relevant, which sectors are too important to leave to chance. It is poor at picking individual winners, because selecting between two early-stage companies requires commercial judgement, sectoral knowledge and a tolerance for failure that no appraisal committee answerable to audit can sustain.
So the RDIF splits the task. The government sets the priorities and the eligibility floor; professional managers with their own reputations and, crucially, their own capital at risk make the company-level calls.
The approval chain shows the two logics coexisting. Applications from the first call, launched in January 2026, went through objective assessment and in-person interaction with an Expert Advisory Committee, then to the Executive Council of ANRF, then to the EGoS. Commercial selection at the bottom; governmental approval at the top.
Where it sits also matters: the RDIF is managed by an Independent Business Unit housed within the Anusandhan National Research Foundation (ANRF), under the Department of Science and Technology. The word "independent" is carrying weight. Investment decisions need speed and a risk appetite a ministry cannot have, so the fund is walled off inside the research foundation rather than run as a departmental scheme.
The two kinds of manager, and why the second kind is the interesting one
Fourteen of the nineteen are Alternative Investment Funds — SEBI-regulated pooled investment vehicles that take equity stakes and seek returns. Conventional, well-understood, and the right instrument for a technology that can become a company.
Five are Focused Research Organisations, and these are not investors at all.
An FRO is a mission-driven research organisation built to solve one well-defined technical problem that neither of the usual institutions will solve. A university will not, because academic incentives reward publications, and the problem may require five years of unglamorous engineering that produces no papers. A company will not, because the payback is too distant and too uncertain for a firm answering to quarterly results. An FRO is staffed, funded and wound up around the problem itself.
Including five of them alongside fourteen AIFs is the most thoughtful feature of this cohort, because it concedes something funds rarely admit: some problems cannot be solved by equity investment. There is no company to invest in, because the enabling science has to be built first. Reserving a share of the corpus for that category — rather than forcing everything through a venture-capital template — is a better design than a pure fund-of-funds would have been.
The floor is set at TRL 4, and that is the point
The release specifies that SLFMs will fund enterprises operating at Technology Readiness Level 4 and above.
That number deserves attention. TRL 4 is roughly the stage at which a component or breadboard has been validated in a laboratory — far from a product, far from a customer, and far from anything a commercial investor normally touches. Indian venture capital, like venture capital everywhere, generally wants to see TRL 7 or higher: a system demonstrated in an operational environment, with early revenue.
The gap between those two points is the financing gap the release names, and it is the same gap examined in the part of innovation where projects die — too applied for a research grant, too unproven for an investor. By setting its floor at TRL 4 rather than TRL 7, the RDIF is explicitly accepting technology risk and not merely scale-up risk. That is what the phrase "long-term, patient capital for high-risk, high-impact research and development" actually commits to, and it distinguishes this fund from a sovereign venture vehicle.
The number that will decide whether this works
Of everything in the release, one sentence carries the most weight: the SLFMs are expected to mobilise private capital equivalent to the RDIF contribution.
A one-to-one match turns ₹7,131 crore of public commitment into roughly ₹14,000 crore of deployable capital. It also sets the test by which this scheme should be judged over the next three years. If private money arrives alongside the public money, the RDIF has done the thing a fund-of-funds is for: it has de-risked a stage that private capital previously avoided, and crowded investors into it. If private money does not arrive, the structure becomes a government grant programme routed through intermediaries who take a fee for the privilege.
There is a structural tension to watch here, and it is the honest criticism of any fund-of-funds. Adding a management layer adds fees and, more importantly, adds an actor whose own commercial survival depends on not losing money. A mandate to make high-risk, high-impact bets sits awkwardly with an intermediary's incentive to protect its track record. The usual drift in such structures is towards safer, later-stage, more fundable companies — which is to say, towards TRL 7 — precisely the behaviour the TRL 4 floor exists to prevent. Whether the floor holds in practice is the thing to monitor.
Two further numbers for proportion. ₹7,131 crore is about 7% of the ₹1 lakh crore corpus, committed roughly eleven months after launch. And nothing has yet reached a company: these are commitments to managers, not disbursements to enterprises. The EGoS also approved five additional technologies for coverage under the Fund, and further cohorts of SLFMs are to be onboarded.
How this fits the rest of the machinery
India now has, at least on paper, a reasonably complete innovation toolkit, and it is worth seeing the pieces together because examiners increasingly ask about the system rather than the scheme.
ANRF funds research. The RDIF, inside it, supplies patient capital for translation from TRL 4 upward. The S&T Clusters under the Principal Scientific Adviser supply the non-financial inputs — pilot sites, first customers, regulatory contacts — and were candid at their own meeting that they convene rather than fund, as set out in eight clusters and an office that convenes rather than funds. Mission-mode capital programmes build the hard capability where only sustained public money will do, which is how India got to 68 petaflops across 40 machines.
The obvious question — and the one that will determine whether this is a system or a collection of schemes — is whether the parts connect. A cluster that introduces a laboratory technology to an SLFM, which then funds it from TRL 4 to a product, would be the architecture working as designed. Nothing in either announcement says that linkage exists yet.
The stated ambition is unambiguous: to move India from a technology consumer to a developer of globally competitive technologies, under the label 'Science 4 Technology', with reduced dependence on imported technology. That is the same argument that runs through standards, patents and semiconductors — that the country which owns the technology sets the terms. A fund is the part of that argument which costs money rather than words.
🔑 Revision block
- What: The Research, Development and Innovation Fund (RDIF) announced its first cohort of 19 Second Level Fund Managers (SLFMs) on 12 October 2026.
- Approval: the Empowered Group of Secretaries (EGoS) on 8 October 2026 approved 14 Alternative Investment Funds (AIFs) and 5 Focused Research Organisations (FROs), total RDIF commitment ₹7,131 crore. Five additional technologies were also approved for coverage.
- The scheme: ₹1 lakh crore RDI Scheme, launched by the Prime Minister in November 2025.
- Where it sits: an Independent Business Unit within the Anusandhan National Research Foundation (ANRF), under the Department of Science and Technology.
- Structure: a fund of funds — the RDIF is the first level; the 19 SLFMs are the second level and invest in Eligible Technology Enterprises (ETEs).
- Why that structure: the state is good at setting strategic priorities and poor at picking individual winners; professional managers with capital at risk make company-level calls.
- Selection chain: first call January 2026 → objective assessment and Expert Advisory Committee interaction → ANRF Executive Council → EGoS.
- AIF vs FRO: an AIF is a SEBI-regulated pooled vehicle taking equity for returns; an FRO is a mission-driven research organisation for a defined problem that academia will not take (incentives reward papers) and industry will not take (payback too distant).
- Eligibility floor: TRL 4 and above — laboratory-validated, far earlier than the TRL 7-plus that commercial investors normally require. The fund therefore accepts technology risk, not just scale-up risk.
- The test: SLFMs are expected to mobilise private capital equivalent to the RDIF contribution — a 1:1 match turning ₹7,131 crore into roughly ₹14,000 crore.
- Risks to watch: fund-of-funds fees, and an intermediary's incentive to protect its record, which pulls investment towards safer later-stage deals and away from the TRL 4 floor. ₹7,131 crore is about 7% of the corpus, and nothing has yet been disbursed to a company.
- Exam hook: 'Science 4 Technology' — long-term patient capital aimed at moving India from technology consumer to technology developer.
🎯 Practice MCQs
Q1. The RDI Fund is best described as: (a) A grant scheme for university laboratories (b) A sovereign wealth fund investing abroad (c) A fund of funds, investing through Second Level Fund Managers (d) A subsidy for technology imports
→ (c) The RDIF is the first-level fund; the approved SLFMs are the second level and invest in Eligible Technology Enterprises.
Q2. The RDI Fund is managed by an Independent Business Unit housed within: (a) The Anusandhan National Research Foundation (b) NITI Aayog (c) The Office of the Principal Scientific Adviser (d) The Securities and Exchange Board of India
→ (a) ANRF sits under the Department of Science and Technology; the "independent" structure gives investment decisions commercial speed.
Q3. The first cohort of Second Level Fund Managers comprises: (a) 19 Alternative Investment Funds only (b) 14 Alternative Investment Funds and 5 Focused Research Organisations (c) 5 Alternative Investment Funds and 14 Focused Research Organisations (d) 19 public sector research institutes
→ (b) Approved by the Empowered Group of Secretaries on 8 October 2026, with a total commitment of ₹7,131 crore.
Q4. A Focused Research Organisation differs from an Alternative Investment Fund in that it: (a) Is regulated by the Reserve Bank of India (b) Invests only in listed companies (c) May only fund government laboratories (d) Is a mission-driven research organisation rather than an investment vehicle
→ (d) It exists for problems that academia will not take because incentives reward publications, and industry will not take because payback is too distant.
Q5. Capital under the Fund flows to Eligible Technology Enterprises operating at: (a) Technology Readiness Level 1 and above (b) Technology Readiness Level 9 only (c) Technology Readiness Level 4 and above (d) Any level, without restriction
→ (c) A floor well below the TRL 7-plus that commercial investors typically require, which means the Fund accepts technology risk.
Q6. The Second Level Fund Managers are expected to mobilise private capital: (a) Equivalent to the RDIF contribution (b) Three times the RDIF contribution (c) Only after full disbursement of public funds (d) Exclusively from foreign investors
→ (a) A one-to-one match, which is the test of whether the Fund has genuinely de-risked a stage private capital previously avoided.
Q7. The body that gave final approval to the first cohort was the: (a) Executive Council of ANRF (b) Empowered Group of Secretaries (c) Expert Advisory Committee (d) Union Cabinet
→ (b) The chain ran from the Expert Advisory Committee, through the ANRF Executive Council, to the EGoS.
Q8. The principal structural risk in a fund-of-funds model for high-risk research is that: (a) Public money cannot legally be invested in equity (b) SEBI does not permit government participation in AIFs (c) Private capital is prohibited from co-investing (d) Intermediaries protecting their track record drift towards safer, later-stage investments
→ (d) Which is precisely the behaviour the TRL 4 floor exists to prevent, and the thing to monitor in practice.
Q9. The ₹1 lakh crore RDI Scheme was launched in: (a) November 2025 (b) January 2026 (c) August 2024 (d) October 2026
→ (a) The first call for SLFM applications followed in January 2026, and the first cohort was approved in October 2026.
Q10. How does the RDI Fund complement the S&T Clusters under the Principal Scientific Adviser? (a) Both provide equity capital to startups (b) The Clusters regulate the Fund's investments (c) The Clusters convene without funding; the Fund supplies capital without convening (d) The Fund operates only in cities with a cluster
→ (c) Together they cover the financial and non-financial constraints on translation — though nothing yet establishes that the two are formally linked.
📋 How this gets asked (PYQ pattern)
Science-funding questions have become steadily more common in NDA papers as India's research architecture has been rebuilt, and four patterns are worth preparing.
The first is the institutional map, which is where most marks are available. ANRF is the research funding foundation; the RDIF is the ₹1 lakh crore fund inside it; DST is the parent department; the Office of the PSA runs the clusters and advises; PM-STIAC is the advisory council; TDB is the Technology Development Board. Learn each with its parent and its function, because the commonest question asks you to match one to the other.
The second is the acronym expansions: RDIF, SLFM, AIF, FRO, ETE, EGoS, ANRF, TRL. Expand each once and attach it to a role. AIF and FRO in particular are easy to confuse, and the distinction — investment vehicle against mission research organisation — is exactly the sort of thing a two-statement question tests.
The third is the number set: ₹1 lakh crore corpus, ₹7,131 crore first-cohort commitment, 19 managers, 14 AIFs, 5 FROs, TRL 4, November 2025 launch. These are clean and recent, which makes them attractive to examiners.
The fourth, and the one that rewards understanding over recall, is why the structure was chosen. A question may ask the rationale for a fund-of-funds. The answer is that the state sets priorities well and picks companies badly, so company-level judgement is delegated to managers with capital at risk.
For an interview, the strongest line is about the match. Say that the test of this fund is not how much it commits but whether private capital arrives beside it — because a fund-of-funds exists to de-risk a stage, and if no private money follows, it has merely added a layer of fees to a grant. That is a specific, falsifiable judgement, and it is considerably better than praising the size of the corpus.
Preparing for NDA? With any fund or scheme, ask three questions: who decides where the money goes, at what stage it enters, and what would count as proof it worked. Build the base with our NDA study material, follow the daily NDA current affairs, and prepare with our faculty in the upcoming Cavalier courses in Delhi.
✍️ Written by Col Vijyanat Thakur — Faculty, Science & Technology, at The Cavalier. Reviewed by the Cavalier Faculty Desk.